TOCHUKWU AJALLA: Open Payments
NPI 1568171676 · LEESBURG, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$303 in 16 payments from 8 companies in 2025. Trend: 2023 $535 · 2024 $271 · 2025 $303
Food & beverage: $303
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 4 | $64 |
| Novo Nordisk Inc | 3 | $61 |
| GlaxoSmithKline, LLC. | 2 | $43 |
| PFIZER INC. | 2 | $40 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $29 |
| Abbott Laboratories | 1 | $24 |
| Exact Sciences Corporation | 1 | $23 |
| Medtronic, Inc. | 1 | $20 |
Products named: AIRSUPRA, TRELEGY ELLIPTA, Ozempic, XIFAXAN, FREESTYLE LIBRE 3, Cologuard Collection Kit, NURTEC ODT, INTELLIS ADAPTIVESTIM.
Industry payments across FL — which companies pay providers there.
